P4708Continuous flow left ventricular assist devices (LVADs) effectively improve pulmonary hemodynamics in bridge-to-transplant patients with end-stage heart failure

2018 ◽  
Vol 39 (suppl_1) ◽  
Author(s):  
A Gkouziouta ◽  
D Palaiologos ◽  
M Stratinaki ◽  
E Leontiadis ◽  
M Bonios ◽  
...  
2020 ◽  
Vol 8 (9) ◽  
pp. 770-779
Author(s):  
Jadry Gruen ◽  
Cesar Caraballo ◽  
P. Elliott Miller ◽  
Megan McCullough ◽  
Catherine Mezzacappa ◽  
...  

Author(s):  
David A. Ramirez ◽  
Mikayle A. Holm ◽  
Andrew Shaffer ◽  
Paul A. Iaizzo

Abstract Implanting Left ventricular assist devices (LVADs) can be life saving therapies that improve life expectancy for the patients that receive it. The target patient population suffer from end-stage heart failure and are therefore susceptible to morbidities arising from a less than ideal surgical implantation. Importantly, the graft that carries the blood from the LVAD pump to the aorta needs to be sized accordingly so as to not cause any compounding complications. The current typical surgical method, is to perform a visual estimation at the time of implantation. This present study proposes a computational tool that utilizes pre-procedural imaging to better calculate the personalized, ideal, LVAD graft length.


Sign in / Sign up

Export Citation Format

Share Document